1-20 of 328
Category: Editor's Choice
Journal Article
EDITOR'S CHOICE
Prevalence of antifungal allergies in the general population
Journal of Antimicrobial Chemotherapy, Volume 80, Issue 4, April 2025, Pages 1080–1083, https://doi.org/10.1093/jac/dkaf037
Published: 17 February 2025
Journal Article
EDITOR'S CHOICE
Educate, Advocate, Act Now: a sustainable approach to combating antimicrobial resistance TODAY
Journal of Antimicrobial Chemotherapy, Volume 80, Issue 3, March 2025, Pages 607–609, https://doi.org/10.1093/jac/dkae478
Published: 07 January 2025
Journal Article
EDITOR'S CHOICE
Effect of empiric antibiotics against Pseudomonas aeruginosa on mortality in hospitalized patients: a systematic review and meta-analysis
Journal of Antimicrobial Chemotherapy, Volume 80, Issue 2, February 2025, Pages 322–333, https://doi.org/10.1093/jac/dkae422
Published: 03 December 2024
Journal Article
EDITOR'S CHOICE
The distinctive pharmacokinetic profile of rezafungin, a long-acting echinocandin developed in the era of modern pharmacometrics
Journal of Antimicrobial Chemotherapy, Volume 80, Issue 1, January 2025, Pages 18–28, https://doi.org/10.1093/jac/dkae415
Published: 14 November 2024
Journal Article
EDITOR'S CHOICE
Impact of discontinuing routine fluoroquinolone prophylaxis in neutropenic allogeneic haematopoietic stem cell transplant recipients: an observational study Get access
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 12, December 2024, Pages 3289–3296, https://doi.org/10.1093/jac/dkae360
Published: 14 October 2024
Journal Article
EDITOR'S CHOICE
Chloramphenicol versus ceftriaxone for the treatment of pneumonia and sepsis in elderly patients with advanced dementia and functional disability. A propensity-weighted retrospective cohort study Get access
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 11, November 2024, Pages 3007–3015, https://doi.org/10.1093/jac/dkae323
Published: 23 September 2024
Journal Article
EDITOR'S CHOICE
Phage susceptibility testing methods or ‘phagograms’: where do we stand and where should we go? Get access
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 11, November 2024, Pages 2742–2749, https://doi.org/10.1093/jac/dkae325
Published: 13 September 2024
Journal Article
EDITOR'S CHOICE
In vitro activity of olorofim against 507 filamentous fungi including antifungal drug-resistant strains at a tertiary laboratory in Australia: 2020–2023 Get access
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 10, October 2024, Pages 2611–2621, https://doi.org/10.1093/jac/dkae267
Published: 06 August 2024
Journal Article
EDITOR'S CHOICE
Breaking the mould: challenging the status quo of clinical trial response definitions for invasive fungal diseases—a debate
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 8, August 2024, Pages 1786–1793, https://doi.org/10.1093/jac/dkae158
Published: 01 August 2024
Journal Article
EDITOR'S CHOICE
Management of Clostridioides difficile infection: an Italian Delphi consensus
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 9, September 2024, Pages 2103–2118, https://doi.org/10.1093/jac/dkae179
Published: 13 July 2024
Journal Article
EDITOR'S CHOICE
Implication of genotypes for prognosis of Candida glabrata bloodstream infections
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 8, August 2024, Pages 2008–2016, https://doi.org/10.1093/jac/dkae200
Published: 22 June 2024
Journal Article
EDITOR'S CHOICE
Global epidemiology and antimicrobial resistance of Enterobacterales harbouring genes encoding OXA-48-like carbapenemases: insights from the results of the Antimicrobial Testing Leadership and Surveillance (ATLAS) programme 2018–2021 Get access
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 7, July 2024, Pages 1581–1589, https://doi.org/10.1093/jac/dkae140
Published: 17 May 2024
Journal Article
EDITOR'S CHOICE
Implementation of the EUCAST rapid antimicrobial susceptibility test (RAST) for carbapenemase/ESBL-producing Escherichia coli and Klebsiella pneumoniae isolates, and its effect on mortality Get access
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 7, July 2024, Pages 1540–1546, https://doi.org/10.1093/jac/dkae125
Published: 10 May 2024
Journal Article
EDITOR'S CHOICE
Impact of removing ESBL status labelling from culture reports on the use of carbapenems for non-bacteraemic patients diagnosed with ESBL-positive urinary tract infections Get access
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 7, July 2024, Pages 1564–1568, https://doi.org/10.1093/jac/dkae135
Published: 08 May 2024
Journal Article
EDITOR'S CHOICE
Isavuconazole as prophylaxis and therapy for invasive fungal diseases: a real-life observational study
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 8, August 2024, Pages 1801–1810, https://doi.org/10.1093/jac/dkae139
Published: 27 April 2024
Journal Article
EDITOR'S CHOICE
Impact of the phenotypic expression of temocillin resistance in Escherichia coli on temocillin efficacy in a murine peritonitis model
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 5, May 2024, Pages 1051–1059, https://doi.org/10.1093/jac/dkae072
Published: 19 March 2024
Journal Article
EDITOR'S CHOICE
Corynebacterium diphtheriae and Corynebacterium ulcerans: development of EUCAST methods and generation of data on which to determine breakpoints
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 5, May 2024, Pages 968–976, https://doi.org/10.1093/jac/dkae056
Published: 18 March 2024
Journal Article
EDITOR'S CHOICE
Comparison of the French novel disc diffusion-based algorithm and the current EUCAST guidelines for the screening of carbapenemase-producing Enterobacterales
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 5, May 2024, Pages 1194–1196, https://doi.org/10.1093/jac/dkae054
Published: 27 February 2024
Journal Article
EDITOR'S CHOICE
Do dietary interventions exert clinically important effects on the bioavailability of β-lactam antibiotics? A systematic review with meta-analyses
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 4, April 2024, Pages 722–757, https://doi.org/10.1093/jac/dkae028
Published: 09 February 2024
Journal Article
EDITOR'S CHOICE
Comparison of daptomycin and glycopeptide efficacy and safety for the treatment of Gram-positive infections: a systematic review and meta-analysis
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 4, April 2024, Pages 712–721, https://doi.org/10.1093/jac/dkae026
Published: 07 February 2024
